ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2755

The Clinical Significance and Natural History Of Knee Bone Marrow Lesions Over 8 Years

Yi Chao Foong1, Hussain Ijaz Khan1, Dawn Aitken1, Changhai Ding2, Flavia Cicuttini3 and Graeme Jones2, 1Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart, 7000, Australia, 2Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, 3Department of Epidemiology and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, 3004, Australia

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Bone marrow, Knee, Lesions, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis II: Risk Factors and Natural History of Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

There is increasing evidence to suggest that bone marrow lesions (BMLs) play a key role in the pathogenesis of OA. Whilst many studies have focused on short and medium term changes in BMLs, no study has explored BMLs over longer timeframes. The aim of this study was to describe the natural history of knee BMLs and their association with knee pain over eight years.

Methods:

199 subjects which consisted of 109 adult offspring of subjects who had a knee replacement and 90 controls who were initially matched by age and sex were studied.  BMLs were measured at the two and ten year follow-ups using T2 weighted fat saturation MRI measuring the maximum area of the lesion at the medial and lateral tibial/femoral and patella sites. Knee pain was assessed by the Western Ontario and McMaster Universities Arthritis Index (WOMAC).

Multiple linear and logistic regression models were performed to investigate potential associations between BMLs and pain.

Results:

At the two year follow-up, 64% of participants (n=128/199) had one or more BMLs, with a total of 231 BMLs present. Over eight years, of the 231 BMLs, 71% (164/231) increased in size, 8% (18/231) remained stable and 21% (49/231) decreased in size or resolved completely (Figure 1). Of those participants with no BMLs at baseline (71/199), 52% (37/71) developed one or more incident BMLs. In the whole sample, 31% of participants (62/199) developed a new BML at 1 site, 22% (44/199) at 2 sites, 9% (18/199) at 3 sites and 1% (2/199) at 4 sites or more. BML natural history did not vary between offspring and controls.

After adjusting for age, sex and BMI, the development of a new BML was associated with developing pain in those without pain at baseline (β=3.71, 95% CI 1.02-6.41). Those with a large BML at two years also had greater odds of having pain at ten years (OR=1.95, 95% CI 1.05-3.62). Eight year change in total BML size predicted an increase in total WOMAC pain in offspring but not controls (Table 1). The magnitude of the association in offspring was stronger in males as compared to females.

Conclusion:

Over eight years, the proportion of BMLs increasing in size was more than triple those decreasing in size and stable BMLs were rare. Incident BMLs were common, with slightly over half of our participants developing new BMLs, whilst one-fifth of BMLs resolved. Change in BML size was associated with pain only in those with a strong family history of OA, suggesting that knee pain associated with BMLs may have a genetic component.

 

Table 1: Change in WOMAC pain score per change in BML size (linear regression)

 

Univariable

β (95% CI)

Multivariable*

β (95% CI)

Females*

β (95% CI)

Males*

β (95% CI)

Total

0.46 (-0.17, 1.08)

0.47 ( -0.16, 1.11)

0.14 (-0.58, 0.87)

2.49 (0.86, 4.12)

Controls

-0.09 ( -0.71, 0.53)

-0.04 (-0.69, 0.60)

-0.14 (-0.93, 0.66)

1.56 (-1.10, 4.23)

Offspring

2.68 (1.22, 4.13)

2.65 (1.20, 4.10)

2.22 (0.10, 4.34)

3.17 (1.04, 5.31)

*Adjusted for age, sex, BMI.

β coefficients are the change in pain score per unit change in BML size (cm2).

 

Figure1: Natural history of BMLs

 

 


Disclosure:

Y. C. Foong,
None;

H. I. Khan,
None;

D. Aitken,
None;

C. Ding,
None;

F. Cicuttini,
None;

G. Jones,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-clinical-significance-and-natural-history-of-knee-bone-marrow-lesions-over-8-years/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology